These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 6812693)

  • 1. Short-term control of brittle diabetes using a Biostator.
    Connor H; Atkin G; Attwood E
    Br Med J (Clin Res Ed); 1982 Nov; 285(6351):1316-7. PubMed ID: 6812693
    [No Abstract]   [Full Text] [Related]  

  • 2. Insulin treatment and state of control before, during, and after connection to a glucose controlled insulin infusion system (Biostator).
    Christiansen JS; Svendsen PA; Deckert T
    Horm Metab Res Suppl; 1979; (8):131-4. PubMed ID: 395069
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Portable insulin infusion systems in juvenile-onset diabetes.
    Tamborlane WV
    Hosp Pract; 1980 Oct; 15(10):91-9. PubMed ID: 6998857
    [No Abstract]   [Full Text] [Related]  

  • 4. Comparison of a perfusion syringe (Mill Hill Infusor) and a glucose-controlled insulin infusion system in the regulation of diabetes mellitus.
    Stavljenić A; Granić M; Topić B; Skrabalo Z
    Horm Metab Res Suppl; 1979; (8):207-11. PubMed ID: 395083
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preprogrammed insulin infusion with a portable pump system.
    Irsigler K; Kritz H; Kaspar L; Brändle J; Koller W; Franetzki M
    Horm Metab Res Suppl; 1979; (8):193-7. PubMed ID: 119699
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biostator Glucose Controller: a building block of the future.
    Young A; Herf S
    Diabetes Educ; 1984; 10(2):11-2. PubMed ID: 6378557
    [No Abstract]   [Full Text] [Related]  

  • 7. Comparison of 24-hour insulin requirements in IDDM patients during control by an artificial betacell and during conventional therapy.
    Christiansen JS; Svendsen PA; Mathiesen E; Rubin P; Deckert T
    Horm Metab Res; 1981 Oct; 13(10):537-41. PubMed ID: 7028586
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Waveform requirements for metabolic normalization with continuous intravenous insulin delivery in man.
    Perlman K; Ehrlich RM; Filler RM; Albisser AM
    Diabetes; 1981 Sep; 30(9):710-7. PubMed ID: 7021271
    [No Abstract]   [Full Text] [Related]  

  • 9. Clinical features of brittle diabetic patients unresponsive to optimized subcutaneous insulin therapy (continuous subcutaneous insulin infusion).
    Pickup J; Williams G; Johns P; Keen H
    Diabetes Care; 1983; 6(3):279-84. PubMed ID: 6409572
    [No Abstract]   [Full Text] [Related]  

  • 10. Insulin-dependent diabetic patients during surgery and labour. Use of continuous intravenous insulin-glucose-potassium infusions.
    Bowen DJ; Daykin AP; Nancekievill ML; Norman J
    Anaesthesia; 1984 May; 39(5):407-11. PubMed ID: 6375445
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pump and brittle circumstance.
    Vaisrub S
    JAMA; 1980 Jun; 243(22):2331-2. PubMed ID: 6990038
    [No Abstract]   [Full Text] [Related]  

  • 12. Reduction to normal of plasma glucose in juvenile diabetes by subcutaneous administration of insulin with a portable infusion pump.
    Tamborlane WV; Sherwin RS; Genel M; Felig P
    N Engl J Med; 1979 Mar; 300(11):573-8. PubMed ID: 763270
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Insulin needs of insulin-dependent diabetics during biostator control and subcutaneous use of insulin].
    Petkova M; Khristov V; Tsanev A
    Vutr Boles; 1990; 29(1):74-7. PubMed ID: 2204207
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Insulin therapy by subcutaneous infusion using a portable pump. A simple method to stabilize brittle diabetics (author's transl)].
    Berger W; Schwarz U; Kaegi E; Keller U; Viollier E
    Schweiz Rundsch Med Prax; 1979 Dec; 68(49):1620-9. PubMed ID: 397488
    [No Abstract]   [Full Text] [Related]  

  • 15. [Treatment of type I diabetics with a combination of Superdep + DEP + NZI and an adjustment of the insulin dosage by means of a Biostator].
    Kábrt J; Masek Z; Páv J; Skrha J; Hodinár A
    Vnitr Lek; 1986 Apr; 32(4):373-8. PubMed ID: 3523974
    [No Abstract]   [Full Text] [Related]  

  • 16. [Continuous predetermined infusion in insulin dependent diabetes in children and adolescents. A comparative study in relation to insulin infusion and duration of diabetes (author's transl)].
    Jean R; Rolin B; Viguier JL; Morel G; Branchet A
    Ann Pediatr (Paris); 1981 Sep; 28(7):485-92. PubMed ID: 7025729
    [No Abstract]   [Full Text] [Related]  

  • 17. Infusion-pump treatment of diabetes mellitus.
    Felig P; Tamborlane W; Sherwin RS; Genel M
    N Engl J Med; 1979 Aug; 301(5):268-9. PubMed ID: 449998
    [No Abstract]   [Full Text] [Related]  

  • 18. Infusion-pump treatment of diabetes mellitus.
    Service FJ; Rizza RA; Gerich JE
    N Engl J Med; 1979 Aug; 301(5):267-8. PubMed ID: 449996
    [No Abstract]   [Full Text] [Related]  

  • 19. [Use of an artifical pancreas and portable pumps in the treatment of juvenile diabetes].
    Buysschaert M; Lambotte L; Lambert AE
    Journ Annu Diabetol Hotel Dieu; 1980 May; ():35-46. PubMed ID: 6995675
    [No Abstract]   [Full Text] [Related]  

  • 20. Predicting insulin requirements for a portable insulin pump using the Biostator. Evidence for reversible insulin resistance in poorly controlled type I diabetics.
    Mayfield RK; Sullivan FM; Colwell JA; Wohltmann HJ
    Diabetes; 1983 Oct; 32(10):908-14. PubMed ID: 6352376
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.